Early ejaculation (PE) affects a significant number of men with underlying erection problems. The standard treatment for hardening problems is the use of drugs called PDE-5 inhibitors (for example, Viagra, Cialis, and Levitra). At present, it is not clear whether adding the new depoxetine drug to men who are successfully treated with underlying erectile dysfunction will improve early discharge symptoms.

The main purpose of this study is to evaluate the effectiveness of a 12-week treatment in prolonging time compared to two doses of dapoxetine (treatment when necessary) and placeboa (cup treatment). On ejaculation in men with PE. ED, which is already treated with a PDE-5 inhibitor.